Terkko Navigator / Kampman, O(lli)

Differences in psychosocial functioning between psychotic disorders in the Finnish SUPER study

Adverse childhood experiences and social and occupational functioning in first-episode psychosis - A one year follow - up

The role of alcohol use and adiposity in serum levels of IL-1RA in depressed patients

Implementation of CYP2D6 copy-number imputation panel and frequency of key pharmacogenetic variants in Finnish individuals with a psychotic disorder

Reaction Time and Visual Memory in Connection to Hazardous Drinking Polygenic Scores in Schizophrenia, Schizoaffective Disorder and Bipolar Disorder

Impact of Comorbid Alcohol Use Disorder on Health-Related Quality of Life Among Patients With Depressive Symptoms

Glucagon-like peptide-1 serum levels are associated with weight gain in patients treated with clozapine

Reaction Time and Visual Memory in Connection to Alcohol Use in Persons with Bipolar Disorder

Electroconvulsive therapy increases temporarily plasma vascular endothelial growth factor in patients with major depressive disorder

Reaction Time and Visual Memory in Connection with Alcohol Use in Schizophrenia and Schizoaffective Disorder

Daily functioning and symptom factors contributing to attitudes toward antipsychotic treatment and treatment adherence in outpatients with schizophrenia spectrum disorders

Importance of congruence between communicating and executing implementation programmes: a qualitative study of focus group interviews

Clozapine-Related Diarrhea and Colitis: Report of 4 Cases

Association of Income With the Incidence Rates of First Psychiatric Hospital Admissions in Finland, 1996-2014

Implementing physical exercise and music interventions for patients suffering from dementia on an acute psychogeriatric inpatient ward

What is important for the sustained implementation of evidence-based brief psychotherapy interventions in psychiatric care? A quantitative evaluation of a real-world programme

Assessment of alcohol consumption in depression follow-up using self-reports and blood measures including inflammatory biomarkers

Status of inflammation and alcohol use in a 6-month follow-up study of patients with major depressive disorder

The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depression

Outcome of neuropsychiatric symptoms and daily functioning of patients with dementia treated on an acute psychogeriatric ward

Pessimism, diet, and the ability to improve dietary habits: a three-year follow-up study among middle-aged and older Finnish men and women

Effect of electroconvulsive therapy on brain-derived neurotrophic factor levels in patients with major depressive disorder

Behavioral activation versus treatment as usual in naturalistic sample of psychiatric patients with depressive symptoms: a benchmark controlled trial

Temperament clusters associate with anxiety disorder comorbidity in depression

Temperament and character profiles are associated with depression outcome in psychiatric secondary care patients with harmful drinking

Low tumor necrosis factor-α levels predict symptom reduction during electroconvulsive therapy in major depressive disorder

The effects of adiposity and alcohol use disorder on adipokines and biomarkers of inflammation in depressed patients

Genetic Polymorphisms Associated With Constipation and Anticholinergic Symptoms in Patients Receiving Clozapine

Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder

BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depression

The association of alcohol use and quality of life in depressed and non-depressed individuals: a cross-sectional general population study

Anxiety Disorders and Temperament-an Update Review

Histaminergic gene polymorphisms associated with sedation in clozapine-treated patients

INSIG2 polymorphism and weight gain, dyslipidemia and serum adiponectin in Finnish patients with schizophrenia treated with clozapine

Changes in interleukin-6 levels during electroconvulsive therapy may reflect the therapeutic response in major depression

Pessimism and risk of death from coronary heart disease among middle-aged and older Finns: an eleven-year follow-up study

Association study of arcuate nucleus neuropeptide Y neuron receptor gene variation and serum NPY levels in clozapine treated patients with schizophrenia

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response

Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine

Temperament and character profiles associated with depression and treatment response in patients with or without comorbid substance abuse

Outcome of patients with dual diagnosis in secondary psychiatric care

Acute Psychogeriatric Inpatient Treatment Improves Neuropsychiatric Symptoms but Impairs the Level of Functioning in Patients with Dementia

Psychiatric hospital admission and long-term care in patients with very-late-onset schizophrenia-like psychosis

Early assessment of implementing evidence-based brief therapy interventions among secondary service psychiatric therapists

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response

SERT and NET polymorphisms, temperament and antidepressant response

Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET) gene polymorphisms: susceptibility and treatment response of electroconvulsive therapy in treatment resistant depression

Association study of the HTR2C, leptin and adiponectin genes and serum marker analyses in clozapine treated long-term patients with schizophrenia

Factors associated with subjective side-effects during clozapine treatment

Polymorphism in alpha 2A adrenergic receptor gene is associated with sialorrhea in schizophrenia patients on clozapine treatment